<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">33176821</PMID><DateCompleted><Year>2021</Year><Month>08</Month><Day>19</Day></DateCompleted><DateRevised><Year>2024</Year><Month>08</Month><Day>03</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1743-422X</ISSN><JournalIssue CitedMedium="Internet"><Volume>17</Volume><Issue>1</Issue><PubDate><Year>2020</Year><Month>Nov</Month><Day>11</Day></PubDate></JournalIssue><Title>Virology journal</Title><ISOAbbreviation>Virol J</ISOAbbreviation></Journal><ArticleTitle>Recent advances of enterovirus 71 [Formula: see text] targeting Inhibitors.</ArticleTitle><Pagination><StartPage>173</StartPage><MedlinePgn>173</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">173</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s12985-020-01430-x</ELocationID><Abstract><AbstractText>With CA16, enterovirus-71 is the causative agent of hand foot and mouth disease (HFMD) which occurs mostly in children under 5 years-old and responsible of several outbreaks since a decade. Most of the time, HFMD is a mild disease but can progress to severe complications such as meningitis, brain stem encephalitis, acute flaccid paralysis (AFP) and even death; EV71 has been identified in all severe cases. Therefore, it is actually one of&#xa0;the most public health issues that threatens children's life. [Formula: see text] is a protease which plays important functions in EV71 infection. To date, a lot of [Formula: see text] inhibitors have been tested but none of them has been approved yet. Therefore, a drug screening is still an utmost importance in order to treat and/or prevent EV71 infections. This work highlights the EV71 life cycle, [Formula: see text] functions and [Formula: see text] inhibitors recently screened. It permits to well understand all mechanisms about [Formula: see text] and consequently allow further development of drugs targeting [Formula: see text]. Thus, this review is helpful for screening of more new [Formula: see text] inhibitors or for designing analogues of well known [Formula: see text] inhibitors in order to improve its antiviral activity.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Diarimalala</LastName><ForeName>Rominah Onintsoa</ForeName><Initials>RO</Initials><AffiliationInfo><Affiliation>National 111 Center for Cellular Regulation and Molecular Pharmaceutics, Key Laboratory of Fermentation (Ministry of Education), Hubei Provincial Cooperative Innovation Center of Industrial Fermentation, Hubei Key Laboratory of Industrial Microbiology, Sino-German Biomedical Center, Hubei University of Technology, Wuhan, China.</Affiliation><Identifier Source="GRID">grid.411410.1</Identifier><Identifier Source="ISNI">0000 0000 8822 034X</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hu</LastName><ForeName>Meichun</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>National 111 Center for Cellular Regulation and Molecular Pharmaceutics, Key Laboratory of Fermentation (Ministry of Education), Hubei Provincial Cooperative Innovation Center of Industrial Fermentation, Hubei Key Laboratory of Industrial Microbiology, Sino-German Biomedical Center, Hubei University of Technology, Wuhan, China.</Affiliation><Identifier Source="GRID">grid.411410.1</Identifier><Identifier Source="ISNI">0000 0000 8822 034X</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wei</LastName><ForeName>Yanhong</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>National 111 Center for Cellular Regulation and Molecular Pharmaceutics, Key Laboratory of Fermentation (Ministry of Education), Hubei Provincial Cooperative Innovation Center of Industrial Fermentation, Hubei Key Laboratory of Industrial Microbiology, Sino-German Biomedical Center, Hubei University of Technology, Wuhan, China.</Affiliation><Identifier Source="GRID">grid.411410.1</Identifier><Identifier Source="ISNI">0000 0000 8822 034X</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hu</LastName><ForeName>Kanghong</ForeName><Initials>K</Initials><Identifier Source="ORCID">0000-0002-5913-2767</Identifier><AffiliationInfo><Affiliation>National 111 Center for Cellular Regulation and Molecular Pharmaceutics, Key Laboratory of Fermentation (Ministry of Education), Hubei Provincial Cooperative Innovation Center of Industrial Fermentation, Hubei Key Laboratory of Industrial Microbiology, Sino-German Biomedical Center, Hubei University of Technology, Wuhan, China.</Affiliation><Identifier Source="GRID">grid.411410.1</Identifier><Identifier Source="ISNI">0000 0000 8822 034X</Identifier></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>11</Month><Day>11</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Virol J</MedlineTA><NlmUniqueID>101231645</NlmUniqueID><ISSNLinking>1743-422X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000998">Antiviral Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D004791">Enzyme Inhibitors</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D019384">Nucleic Acid Synthesis Inhibitors</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D012367">RNA, Viral</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000998" MajorTopicYN="N">Antiviral Agents</DescriptorName><QualifierName UI="Q000302" MajorTopicYN="N">isolation &amp; purification</QualifierName><QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004353" MajorTopicYN="N">Drug Evaluation, Preclinical</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName><QualifierName UI="Q000639" MajorTopicYN="N">trends</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D029821" MajorTopicYN="N">Enterovirus A, Human</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName><QualifierName UI="Q000201" MajorTopicYN="N">enzymology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004791" MajorTopicYN="N">Enzyme Inhibitors</DescriptorName><QualifierName UI="Q000302" MajorTopicYN="N">isolation &amp; purification</QualifierName><QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006232" MajorTopicYN="N">Hand, Foot and Mouth Disease</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019384" MajorTopicYN="N">Nucleic Acid Synthesis Inhibitors</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010802" MajorTopicYN="N">Phylogeny</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012367" MajorTopicYN="N">RNA, Viral</DescriptorName><QualifierName UI="Q000037" MajorTopicYN="Y">antagonists &amp; inhibitors</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">EV71 drugs screening</Keyword><Keyword MajorTopicYN="N">Enterovirus 71</Keyword><Keyword MajorTopicYN="N">Enterovirus 71&#xa0;life cycle</Keyword><Keyword MajorTopicYN="N">functions</Keyword><Keyword MajorTopicYN="N">inhibitors</Keyword></KeywordList><CoiStatement>Not applicable.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>8</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>10</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>11</Month><Day>12</Day><Hour>5</Hour><Minute>30</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>11</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>8</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2020</Year><Month>11</Month><Day>11</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33176821</ArticleId><ArticleId IdType="pmc">PMC7657364</ArticleId><ArticleId IdType="doi">10.1186/s12985-020-01430-x</ArticleId><ArticleId IdType="pii">1430</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Schmidt NJ, Lennette EH, Ho HH. An apparently new enterovirus isolated from patients with disease ofthe central nervous system. J Infect Dis. 1974;129(3):304&#x2013;309. doi: 10.1093/infdis/129.3.304.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/129.3.304</ArticleId><ArticleId IdType="pubmed">4361245</ArticleId></ArticleIdList></Reference><Reference><Citation>Putnak JR, Phillips BA. Picornaviral structure and assembly. Microbiol Rev. 1981;45(2):287&#x2013;315. doi: 10.1128/mmbr.45.2.287-3l5.l98l.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/mmbr.45.2.287-3l5.l98l</ArticleId><ArticleId IdType="pmc">PMC281510</ArticleId><ArticleId IdType="pubmed">7022155</ArticleId></ArticleIdList></Reference><Reference><Citation>Yuan J, et al. Enterovirus A71 proteins: structure and function. Front Microbiol. 2018;9:286. doi: 10.3389/fmicb.2018.00286.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2018.00286</ArticleId><ArticleId IdType="pmc">PMC5826392</ArticleId><ArticleId IdType="pubmed">29515559</ArticleId></ArticleIdList></Reference><Reference><Citation>Solomon T, Lewthwaite P, Perera D, Cardosa MJ, McMinn P, Ooi MH. Virology, epidemiology, pathogenesis, and control of enterovirus 71. Lancet Infect Dis. 2010;10(11):778&#x2013;790. doi: 10.1016/S1473-3099(10)70194-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(10)70194-8</ArticleId><ArticleId IdType="pubmed">20961813</ArticleId></ArticleIdList></Reference><Reference><Citation>Zeng M, et al. Seroepidemiology of Enterovirus 71 infection prior to the 2011 season in children in Shanghai. J Clin Virol. 2012;53(4):285&#x2013;289. doi: 10.1016/j.jcv.2011.12.025.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcv.2011.12.025</ArticleId><ArticleId IdType="pubmed">22265829</ArticleId></ArticleIdList></Reference><Reference><Citation>Podin Y, et al. Sentinel surveillance for human enterovirus 71 in Sarawak, Malaysia: lessons from the first 7 years. BMC Public Health. 2006;6:180. doi: 10.1186/1471-2458-6-180.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2458-6-180</ArticleId><ArticleId IdType="pmc">PMC1543637</ArticleId><ArticleId IdType="pubmed">16827926</ArticleId></ArticleIdList></Reference><Reference><Citation>Mizuta K, et al. Molecular epidemiology of enterovirus 71 strains isolated from children in Yamagata, Japan, between 1990 and 2013. J Med Microbiol. 2014;63:1356&#x2013;1362. doi: 10.1099/jmm.0.079699-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/jmm.0.079699-0</ArticleId><ArticleId IdType="pubmed">25053796</ArticleId></ArticleIdList></Reference><Reference><Citation>Te Lee J, et al. Enterovirus 71 seroepidemiology in Taiwan in 2017 and comparison of those rates in 1997, 1999 and 2007. PLoS ONE. 2019;14(10):e0224110. doi: 10.1371/journal.pone.0224110.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0224110</ArticleId><ArticleId IdType="pmc">PMC6797108</ArticleId><ArticleId IdType="pubmed">31622436</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Le T, Nguyen VTT, Nguyen QH, Pham DT. Molecular epidemiology analysis of enterovirus 71 strains isolated in Dak Lak, Vietnam, 2011&#x2013;2016. J Med Virol. 2019;91(1):56&#x2013;64. doi: 10.1002/jmv.25286.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.25286</ArticleId><ArticleId IdType="pubmed">30132913</ArticleId></ArticleIdList></Reference><Reference><Citation>Liang Z, Wang J. EV71 vaccine, an invaluable gift for children. Clin Transl Immunol. 2014;3(10):e28. doi: 10.1038/cti.2014.24.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/cti.2014.24</ArticleId><ArticleId IdType="pmc">PMC4237031</ArticleId><ArticleId IdType="pubmed">25505956</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin JY, Kung YA, Shih SR. Antivirals and vaccines for Enterovirus A71. J Biomed Sci. 2019;26(1):65. doi: 10.1186/sl2929-0l9-0560-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/sl2929-0l9-0560-7</ArticleId><ArticleId IdType="pmc">PMC6720414</ArticleId><ArticleId IdType="pubmed">31481071</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin C, Chen KH, Tong Chen K. Update on enterovirus 71 infections: epidemiology, molecular epidemiology, and vaccine development. J Infect Dis Ther. 2018 doi: 10.4172/2332-0877.1000370.</Citation><ArticleIdList><ArticleId IdType="doi">10.4172/2332-0877.1000370</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang H, Li Y. Recent progress on functional genomics research of enterovirus 71. Virol Sin. 2019;34(1):9&#x2013;21. doi: 10.1007/sl2250-0l8-007l-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/sl2250-0l8-007l-9</ArticleId><ArticleId IdType="pmc">PMC6420560</ArticleId><ArticleId IdType="pubmed">30552635</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamayoshi S, Fujii K, Koike S. Receptors for enterovirus 71. Emerg Microbes Infect. 2014;3:e53. doi: 10.1038/emi.2014.49.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/emi.2014.49</ArticleId><ArticleId IdType="pmc">PMC4126179</ArticleId><ArticleId IdType="pubmed">26038749</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu Y, Liu Q, Zhang Z. Human EV71 invades human neuroblastoma SK-N-SH cells by clathrin-mediated endocytosis. Xi Bao Yu Fen Zi Mian Yi XueZaZhi. 2017;33(6):761&#x2013;766.</Citation><ArticleIdList><ArticleId IdType="pubmed">28615098</ArticleId></ArticleIdList></Reference><Reference><Citation>Yuan M, et al. Enhanced human enterovirus 71 infection by endocytosis inhibitors reveals multiple entry pathways by enterovirus causing hand-foot-and-mouth diseases. Virol J. 2018;15(1):1. doi: 10.1186/sl2985-0l7-09l3-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/sl2985-0l7-09l3-3</ArticleId><ArticleId IdType="pmc">PMC5751926</ArticleId><ArticleId IdType="pubmed">29298696</ArticleId></ArticleIdList></Reference><Reference><Citation>Danthi P, Tosteson M, Li Q, Chow M. Genome delivery and ion channel properties are altered in VP4 mutants of poliovirus. J Virol. 2003;77(9):5266&#x2013;5274. doi: 10.1128/jvi.77.9.5266-5274.2003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jvi.77.9.5266-5274.2003</ArticleId><ArticleId IdType="pmc">PMC153979</ArticleId><ArticleId IdType="pubmed">12692228</ArticleId></ArticleIdList></Reference><Reference><Citation>Baggen J, Thibaut HJ, Strating JR, van Kuppeveld FJ. The life cycle of non-polio enteroviruses and how to target it. Nat Rev Microbiol. 2018;16(6):368&#x2013;381. doi: 10.1038/s4l579-0l8-0005-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s4l579-0l8-0005-4</ArticleId><ArticleId IdType="pubmed">29626210</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang PN, et al. Far upstream element binding protein 1 binds the internal ribosomal entry site of enterovirus 71 and enhances viral translation and viral growth. Nucleic Acids Res. 2011;39(22):9633&#x2013;9648. doi: 10.1093/nar/gkr682.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkr682</ArticleId><ArticleId IdType="pmc">PMC3239202</ArticleId><ArticleId IdType="pubmed">21880596</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin JY, Li ML, Shih SR. Far upstream element binding protein 2 interacts with enterovirus 71 internal ribosomal entry site and negatively regulates viral translation. Nucleic Acids Res. 2009;37(1):47&#x2013;59. doi: 10.1093/nar/gkn901.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkn901</ArticleId><ArticleId IdType="pmc">PMC2615614</ArticleId><ArticleId IdType="pubmed">19010963</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang J, et al. Crystal structures of enterovirus 71 3C protease complexed with rupintrivir reveal the roles of catalytically important residues. J Virol. 2011;85(19):10021&#x2013;10030. doi: 10.1128/jvi.05l07-ll.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jvi.05l07-ll</ArticleId><ArticleId IdType="pmc">PMC3196404</ArticleId><ArticleId IdType="pubmed">21813612</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma HY, et al. Association of EV713C polymorphisms with clinical severity. J Microbiol Immunol Infect. 2018;51(5):608&#x2013;613. doi: 10.1016/j.jmii.2016.12.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jmii.2016.12.006</ArticleId><ArticleId IdType="pubmed">28711442</ArticleId></ArticleIdList></Reference><Reference><Citation>Bingqing L, et al. A novel enterovirus 71 (EV71) virulence determinant: The 69th residue of 3C protease modulates pathogenicity. Front Cell Infect Microbiol. 2017;7:26. doi: 10.3389/fcimb.2017.00026.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcimb.2017.00026</ArticleId><ArticleId IdType="pmc">PMC5290453</ArticleId><ArticleId IdType="pubmed">28217559</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y, Yang B, Zhai Y, Yin Z, Sun Y, Rao Z. Peptidyl aldehyde NK-1.8k suppresses enterovirus 71 and enterovirus 68 infection by targeting protease 3C. Antimicrob Agents Chemother. 2015;59(5):2636&#x2013;2646. doi: 10.1128/AAC.00049-I5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/AAC.00049-I5</ArticleId><ArticleId IdType="pmc">PMC4394787</ArticleId><ArticleId IdType="pubmed">25691647</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen KR, Ling P. Interplays between enterovirus A71 and the innate immune system. J Biomed Sci. 2019;26(1):95. doi: 10.1186/sl2929-0l9-0596-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/sl2929-0l9-0596-8</ArticleId><ArticleId IdType="pmc">PMC6886175</ArticleId><ArticleId IdType="pubmed">31787104</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang C, et al. Enterovirus 71 suppresses interferon responses by blocking Janus kinase (JAK)/signal transducer and activator of transcription (STAT) signaling through inducing karyopherin-&#x3b1;1 degradation. J Biol Chem. 2017;292(24):10262&#x2013;10274. doi: 10.1074/jbc.Mll6.745729.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.Mll6.745729</ArticleId><ArticleId IdType="pmc">PMC5473229</ArticleId><ArticleId IdType="pubmed">28455446</ArticleId></ArticleIdList></Reference><Reference><Citation>Lei X, Han N, Xiao X, Jin Q, He B, Wang J. Enterovirus 713C inhibits cytokine expression through cleavage of the TAK1/TAB 1/TAB 2/TAB3 complex. J Virol. 2014;88(17):9830&#x2013;9841. doi: 10.1128/jvi.0l425-l4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jvi.0l425-l4</ArticleId><ArticleId IdType="pmc">PMC4136319</ArticleId><ArticleId IdType="pubmed">24942571</ArticleId></ArticleIdList></Reference><Reference><Citation>Lei X, Xiao X, Xue Q, Jin Q, He B, Wang J. Cleavage of interferon regulatory factor 7 by enterovirus 713C suppresses cellular responses. J Virol. 2013;87(3):1690&#x2013;1698. doi: 10.1128/jvi.0l855-l2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jvi.0l855-l2</ArticleId><ArticleId IdType="pubmed">0</ArticleId></ArticleIdList></Reference><Reference><Citation>Li ML, et al. The 3C protease activity of enterovirus 71 induces human neural cell apoptosis. Virology. 2002;293(2):386&#x2013;395. doi: 10.1006/viro.2001.1310.</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/viro.2001.1310</ArticleId><ArticleId IdType="pubmed">11886259</ArticleId></ArticleIdList></Reference><Reference><Citation>Li ML, et al. EV713C protease induces apoptosis by cleavage of hnRNP Al to promote apaf-l translation. PLoS ONE. 2019;14(9):e0221048. doi: 10.1371/journal.pone.0221048.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0221048</ArticleId><ArticleId IdType="pmc">PMC6733512</ArticleId><ArticleId IdType="pubmed">31498791</ArticleId></ArticleIdList></Reference><Reference><Citation>Li J, et al. Enterovirus 713C promotes apoptosis through cleavage of PinXl, a telomere binding protein. J Virol. 2017 doi: 10.1128/jvi.020l6-l6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jvi.020l6-l6</ArticleId><ArticleId IdType="pmc">PMC5215332</ArticleId><ArticleId IdType="pubmed">27847364</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharma R, Raychaudhuri S, Dasgupta A. Nuclear entry of poliovirus protease- polymerase precursor 3CD: implications for host cell transcription shut-off. Virology. 2004;320(2):195&#x2013;205. doi: 10.1016/j.virol.2003.10.020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virol.2003.10.020</ArticleId><ArticleId IdType="pubmed">15016543</ArticleId></ArticleIdList></Reference><Reference><Citation>Weng KF, Li ML, Hung CT, Shih SR. Enterovirus 713C protease cleaves a novel target CstF-64 and inhibits cellular polyadenylation. PLoS Pathog. 2009;5(9):e1000593. doi: 10.1371/journal.ppat.1000593.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1000593</ArticleId><ArticleId IdType="pmc">PMC2742901</ArticleId><ArticleId IdType="pubmed">19779565</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang XN, Song ZG, Jiang T, Shi BS, Hu YW, Yuan ZH. Rupintrivir is a promising candidate for treating severe cases of Enterovirus-71 infection. World J Gastroenterol. 2010;16(2):201&#x2013;209. doi: 10.3748/wjg.vl6.i2.201.</Citation><ArticleIdList><ArticleId IdType="doi">10.3748/wjg.vl6.i2.201</ArticleId><ArticleId IdType="pmc">PMC2806558</ArticleId><ArticleId IdType="pubmed">20066739</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuo CJ, et al. Design, synthesis, and evaluation of 3C protease inhibitors as anti-enterovirus 71 agents. Bioorgan Med Chem. 2008;16(15):7388&#x2013;7398. doi: 10.1016/j.bmc.2008.06.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bmc.2008.06.015</ArticleId><ArticleId IdType="pmc">PMC7125518</ArticleId><ArticleId IdType="pubmed">18583140</ArticleId></ArticleIdList></Reference><Reference><Citation>Shang L, et al. Biochemical characterization of recombinant enterovirus 71 3C protease with fluorogenic model peptide substrates and development of a biochemical assay. Antimicrob Agents Chemother. 2015;59(4):1827&#x2013;1836. doi: 10.1128/AAC.04698-I4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/AAC.04698-I4</ArticleId><ArticleId IdType="pmc">PMC4356770</ArticleId><ArticleId IdType="pubmed">25421478</ArticleId></ArticleIdList></Reference><Reference><Citation>Hung HC, Wang HC, Shih SR, Teng IF, Tseng CP, Hsu JTA. Synergistic inhibition of enterovirus 71 replication by interferon and rupintrivir. J Infect Dis. 2011;203(12):1784&#x2013;1790. doi: 10.1093/infdis/jirl74.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jirl74</ArticleId><ArticleId IdType="pubmed">21536800</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan J, et al. 3C protease of enterovirus 68: structure-based design of Michael acceptor inhibitors and their broad-spectrum antiviral effects against picornaviruses. J Virol. 2013;87(8):4339&#x2013;4351. doi: 10.1128/jvi.0ll23-l2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jvi.0ll23-l2</ArticleId><ArticleId IdType="pmc">PMC3624371</ArticleId><ArticleId IdType="pubmed">23388726</ArticleId></ArticleIdList></Reference><Reference><Citation>Tijsma A, et al. The capsid binder vapendavir and the novel protease inhibitor SG85 inhibit enterovirus 71 replication. Antimicrob Agents Chemother. 2014;58(11):6990&#x2013;6992. doi: 10.1128/AAC.03328-I4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/AAC.03328-I4</ArticleId><ArticleId IdType="pmc">PMC4249361</ArticleId><ArticleId IdType="pubmed">25199773</ArticleId></ArticleIdList></Reference><Reference><Citation>Y Z, et al. Cyanohydrin as an anchoring group for potent and selective inhibitors ofenterovirus 713C protease. J Med Chem. 2015;58(23):9414&#x2013;9420. doi: 10.1021/acs.jmedchem.5b01013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.jmedchem.5b01013</ArticleId><ArticleId IdType="pubmed">26571192</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma Y, et al. 4-Iminooxazolidin-2-one as a Bioisostere of the cyanohydrin moiety: inhibitors of enterovirus 71 3C protease. J Med Chem. 2018;61(22):10333&#x2013;10339. doi: 10.1021/acs.jmedchem.8b01335.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.jmedchem.8b01335</ArticleId><ArticleId IdType="pubmed">30365311</ArticleId></ArticleIdList></Reference><Reference><Citation>Zeng D, et al. Synthesis and structure-activity relationship of &#x3b1;-keto amides as enterovirus 713C protease inhibitors. Bioorgan Med Chem Lett. 2016;26(7):1762&#x2013;1766. doi: 10.1016/j.bmcl.2016.02.039.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bmcl.2016.02.039</ArticleId><ArticleId IdType="pubmed">26916437</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma GH, et al. Identification and biochemical characterization of DC07090 as a novel potent small molecule inhibitor against human enterovirus 71 3C protease by structure-based virtual screening. Eur J Med Chem. 2016;124:981&#x2013;991. doi: 10.1016/j.ejmech.2016.10.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejmech.2016.10.019</ArticleId><ArticleId IdType="pubmed">27776325</ArticleId></ArticleIdList></Reference><Reference><Citation>Zakaryan H, Arabyan E, Oo A, Zandi K. Flavonoids: promising natural compounds against viral infections. Arch Virol. 2017;162(9):2539&#x2013;2551. doi: 10.1007/s00705-0l7-34l7-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00705-0l7-34l7-y</ArticleId><ArticleId IdType="pmc">PMC7087220</ArticleId><ArticleId IdType="pubmed">28547385</ArticleId></ArticleIdList></Reference><Reference><Citation>Cao Z, et al. Luteoloside acts as 3C protease inhibitor of enterovirus 71 in vitro. PLoS ONE. 2016;11(2):e0148693. doi: 10.1371/journal.pone.0148693.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0148693</ArticleId><ArticleId IdType="pmc">PMC4752227</ArticleId><ArticleId IdType="pubmed">26870944</ArticleId></ArticleIdList></Reference><Reference><Citation>Yao C, et al. Inhibition of enterovirus 71 replication and viral 3C protease by quercetin. Virol J. 2018;15(1):116. doi: 10.1186/sl2985-0l8-l023-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/sl2985-0l8-l023-6</ArticleId><ArticleId IdType="pmc">PMC6069798</ArticleId><ArticleId IdType="pubmed">30064445</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang J, Zhang T, Du J, Cui S, Yang F, Jin Q. Anti-enterovirus 71 effects of chrysin and its phosphate ester. PLoS ONE. 2014;9(3):e89668. doi: 10.1371/journal.pone.0089668.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0089668</ArticleId><ArticleId IdType="pmc">PMC3943725</ArticleId><ArticleId IdType="pubmed">24598537</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan EL, Tan TMC, Chow VTK, Poh CL. Inhibition of enterovirus 71 in virusinfected mice by RNA interference. Mol Ther. 2007;15(11):1931&#x2013;1938. doi: 10.1038/sj.mt.6300287.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/sj.mt.6300287</ArticleId><ArticleId IdType="pubmed">17712333</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang Z, Li G, Zhang Y, Liu X, Tien P. A novel minicircle vector based system for inhibting the replication and gene expression of enterovirus 71 and Coxsackievirus A16. Antivir Res. 2012;96(2):234&#x2013;244. doi: 10.1016/j.antiviral.2012.08.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.antiviral.2012.08.003</ArticleId><ArticleId IdType="pubmed">22921338</ArticleId></ArticleIdList></Reference><Reference><Citation>Subramanya S, Kim SS, Manjunath N, Shankar P. RNA interference-based therapeutics for human immunodeficiency virus HIV-I treatment: synthetic siRNA or vectorbased shRNA? Expert Opin Biol Ther. 2010;10(2):201&#x2013;213. doi: 10.1517/14712590903448158.</Citation><ArticleIdList><ArticleId IdType="doi">10.1517/14712590903448158</ArticleId><ArticleId IdType="pmc">PMC3745298</ArticleId><ArticleId IdType="pubmed">20088715</ArticleId></ArticleIdList></Reference><Reference><Citation>Ashfaq UA, Yousaf MZ, Aslam M, Ejaz R, Jahan S, Ullah O. SiRNAs: potential therapeutic agents against Hepatitis C Virus. Virol J. 2011;8:1&#x2013;6. doi: 10.1186/1743-422X-8-276.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1743-422X-8-276</ArticleId><ArticleId IdType="pmc">PMC3118364</ArticleId><ArticleId IdType="pubmed">21645341</ArticleId></ArticleIdList></Reference><Reference><Citation>Fujimoto Y, et al. Antiviral effects against influenza a virus infection by a short hairpin RNA targeting the non-coding terminal region of the viral nucleoprotein gene. J Vet Med Sci. 2019;81(3):383&#x2013;388. doi: 10.1292/jvms.l8-0436.</Citation><ArticleIdList><ArticleId IdType="doi">10.1292/jvms.l8-0436</ArticleId><ArticleId IdType="pmc">PMC6451914</ArticleId><ArticleId IdType="pubmed">30674743</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang W, Peng H, Li J, et al. Controllable inhibition of hepatitis B virus replication by a DR1-targeting short hairpin RNA (shRNA) expressed from a DOX-inducible lentiviral vector. Virus Genes. 2013;46:393&#x2013;403. doi: 10.1007/s11262-013-0886-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11262-013-0886-2</ArticleId><ArticleId IdType="pmc">PMC7089079</ArticleId><ArticleId IdType="pubmed">23397077</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>